FMC1-LUC7L2

Across TCGA pan-cancer cohorts, FMC1-LUC7L2 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of FMC1-LUC7L2’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where FMC1-LUC7L2 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FMC1-LUC7L2 is over-expressed in tumor.

STAD are the cancer types where FMC1-LUC7L2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FMC1-LUC7L2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	III,IV	+0.073	.016	7	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 1 strongest of 1 lineages.

FMC1-LUC7L2–STAD

Open the STAD breakdown →